ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00010426
Recruitment Status : Completed
First Posted : February 2, 2001
Last Update Posted : March 25, 2015
Sponsor:
Collaborator:
Leadiant Biosciences, Inc.
Information provided by:
FDA Office of Orphan Products Development

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2001